Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis

Background— Enteroviruses and adenoviruses have been considered the most common causes of viral myocarditis, but parvovirus B19 (PVB19) and human herpesvirus 6 (HHV6) are increasingly found in endomyocardial biopsy samples. Methods and Results— Consequently, our aim was to evaluate the prevalence and clinical presentation of cardiac PVB19 and/or HHV6 infection in a cohort of myocarditis patients and to follow its clinical course. In addition, we sought to demonstrate patterns of myocardial damage and to determine predictors for chronic heart failure. Our study design consisted of a cardiovascular magnetic resonance protocol as well as endomyocardial biopsies in the myocardial region affected as indicated by cardiovascular magnetic resonance. One hundred twenty-eight patients were enrolled by clinical criteria. In the group of myocarditis patients (n=87), PVB19 (n=49), HHV6 (n=16), and combined PVB19/HHV6 infections (n=15) were detected most frequently. The remaining patients were diagnosed with healing myocarditis (n=15) or did not have myocarditis (n=26). Patients with PVB19 presented in a manner similar to that of myocardial infarction; most had typical subepicardial late gadolinium enhancement in the lateral wall and recovered within months. Conversely, patients with HHV6 and especially with HHV6/PVB19 myocarditis presented with new onset of heart failure, had septal late gadolinium enhancement, and frequently progressed toward chronic heart failure. Conclusions— Our data indicate that PVB19 and HHV6 are the most important causes for viral myocarditis in Germany and that the clinical presentation is related to the type of virus. Furthermore, clinical presentation, type of virus, and pattern of myocardial damage are related to the clinical course.

[1]  J. Riquelme Infección primaria por herpesvirus humano 6. A population-based study of primary human herpesvirus 6 infection. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, et al N Engl J Med 2005; 352 (5): 768-76 , 2005 .

[2]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[3]  H. Schultheiss,et al.  Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.

[4]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[5]  U. Sigwart,et al.  Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. , 2005, Circulation.

[6]  D. Pennell,et al.  Diagnosis of myocarditis by cardiovascular magnetic resonance , 2005, Heart.

[7]  O. Pachinger,et al.  Fatal course of parvovirus B19‐associated myocarditis in a female liver transplant recipient , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[9]  C. Prober Sixth disease and the ubiquity of human herpesviruses. , 2005, The New England journal of medicine.

[10]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[11]  C. Tschöpe,et al.  High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction , 2005, Circulation.

[12]  Wiley Interscience,et al.  Quantitative analysis of human herpesvirus 6 cell tropism , 2005, Journal of medical virology.

[13]  N. Rose,et al.  Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .

[14]  R. Kandolf Virusätiologie der inflammatorischen Kardiomyopathie , 2004 .

[15]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[16]  Robert O. Bonow,et al.  Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition , 2004 .

[17]  N. Rose,et al.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.

[18]  R. Kandolf [Virus etiology of inflammatory cardiomyopathy]. , 2004, Deutsche medizinische Wochenschrift.

[19]  K. Klingel,et al.  Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.

[20]  K. Klingel,et al.  Parvovirus B19 Infection Mimicking Acute Myocardial Infarction , 2003, Circulation.

[21]  J. Towbin,et al.  Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.

[22]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[23]  M. Schoppet,et al.  Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. , 2003, Human pathology.

[24]  H. Schultheiss,et al.  Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .

[25]  B. Maisch,et al.  Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. , 2003, Human pathology.

[26]  K. Klingel,et al.  Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. , 2003, Human pathology.

[27]  H. Schultheiss,et al.  Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.

[28]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[29]  T. Yoshikawa,et al.  Fatal acute myocarditis in an infant with human herpesvirus 6 infection. , 2001, Journal of clinical pathology.

[30]  K. Klingel,et al.  [Epstein-Barr virus-associated pericarditis]. , 2001, Deutsche medizinische Wochenschrift.

[31]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[32]  S. Suvarna,et al.  Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry , 2000, Journal of clinical pathology.

[33]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[34]  ChuichiKawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death , 1999 .

[35]  C. Kawai,et al.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[36]  Heribert Schunkert,et al.  Left-ventricular dysfunction , 1998, The Lancet.

[37]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[38]  W. Roberts,et al.  Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy. , 1993, The American journal of cardiology.

[39]  K. Baughman,et al.  A clinicopathologic description of myocarditis. , 1993, Clinical immunology and immunopathology.

[40]  D. Krikler,et al.  Heart disease: A textbook of cardiovascular medicine , 1992 .

[41]  A. di Lenarda,et al.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. , 1992, American heart journal.

[42]  G. Hutchins,et al.  Clinicopathoiogic description of myocarditis , 1991 .

[43]  E. Fisman,et al.  Sudden unexpected death in persons <40 years of age , 1991 .

[44]  E. Fisman,et al.  Sudden unexpected death in persons less than 40 years of age. , 1991, The American journal of cardiology.

[45]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.

[46]  Lloyd M. Smith,et al.  Fluorescence detection in automated DNA sequence analysis , 1986, Nature.

[47]  J. Lefrère,et al.  [Parvovirus B 19]. , 1986, Presse medicale.

[48]  R. A. Johnson,et al.  Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. , 1985, The New England journal of medicine.

[49]  M. Studdert,et al.  Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. , 1984, The American journal of pathology.

[50]  C. Ray,et al.  Acute polyarthritis associated with active Epstein-Barr virus infection. , 1982, JAMA.

[51]  V. Fuster,et al.  The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.

[52]  E. Fletcher,et al.  Cardiac complications of Coxsackie-virus infection. , 1957, Lancet.

[53]  O. Saphir,et al.  Myocarditis; a classification of 1402 cases. , 1947, American heart journal.